Daniel Arias analyst STIFEL

Currently out of the existing stock ratings of Daniel Arias, 98 are a BUY (70.5%), 41 are a HOLD (29.5%).

Daniel Arias

Work Performance Price Targets & Ratings Chart

Analyst Daniel Arias works at STIFEL with a stock forecast success ratio of 59.13% fulfilled within 132.88 days on average.

Daniel Arias’s has documented 276 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on BRKR, Bruker at 20-May-2024.

Wall Street Analyst Daniel Arias

Analyst best performing recommendations are on WAT (WATERS).
The best stock recommendation documented was for WAT (WATERS) at 5/8/2024. The price target of $332 was fulfilled within 1 day with a profit of $8.2 (2.53%) receiving and performance score of 25.32.

Average potential price target upside

A Agilent Technologies AVTR Avantor BLI Berkeley Lights  BRKR Bruker EXAS EXACT Sciences GH Guardant Health ILMN Illumina LMNX Luminex MASS 908 Devices MRVI Maravai Lifesciences Holdings  RGEN Repligen RNLX Renalytix AI TECH Bio-Techne Corp TMO Thermo Fisher Scientific TXG 10X Genomics WAT Waters ABSI Absci Corp CDXS Codexis DHR Danaher PKI PerkinElmer MTD Mettler-Toledo International NSTG NanoString Technologies QGEN Qiagen NV SLGC Somalogic TX Ternium SA ADR MXCT MaxCyte

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

163

$12.34 (8.19%)

135

1 months 21 days ago

7/9 (77.78%)

$21.66 (15.32%)

81

Hold

132

$-18.66 (-12.39%)

120

2 months 28 days ago

7/8 (87.5%)

$-5.01 (-3.66%)

151

Sell

125

$-25.66 (-17.03%)

120

2 months 28 days ago

10/12 (83.33%)

$-12.01 (-8.77%)

137

Sell

120

$-30.66 (-20.35%)

100

4 months 1 days ago

4/6 (66.67%)

$-9.88 (-7.61%)

109

Buy

165

$14.34 (9.52%)

150

5 months 6 days ago

7/9 (77.78%)

$27.05 (19.61%)

269

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Daniel Arias is most bullish on?

Potential upside of $48.84 has been obtained for RGEN (REPLIGEN)

Which stock is Daniel Arias is most reserved on?

Potential downside of -$15.79 has been obtained for TECH (BIO-TECHNE CORP)

What Year was the first public recommendation made by Daniel Arias?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?